Revenue ($USD) : $484,866,373
Revenue (foreign currencies) : JP¥63,740,000,000
R&D spend : $10,025,947.00
Employees : 5,650
Fiscal year end : 03/31/23
CEO : Ryuji Katsura, president and representative director

Dr. Taro Tsuchiya founded JMS in the 1960s after recognizing the need for disposable medical devices to minimize complications from blood transfusions. Today, JMS offers products and services in areas including infusion/transfusion, nutrition, dialysis, surgery, and blood/cells. The company emphasizes its development approach, centering on real-world clinical needs and collaborating closely with healthcare professionals. –CN